Cornell Pochily Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Sell |
10,724
-127
| -1% | -$16.7K | 0.36% | 70 |
|
|
2026
Q1 | $1.51M | Sell |
10,851
-323
| -3% | -$45.2K | 0.44% | 63 |
|
|
2025
Q4 | $1.37M | Sell |
11,174
-686
| -6% | -$83.4K | 0.4% | 68 |
|
|
2025
Q3 | $1.32M | Buy |
11,860
+48
| +0.4% | +$5.46K | 0.39% | 67 |
|
|
2025
Q2 | $1.31M | Buy |
11,812
+2,349
| +25% | +$250K | 0.43% | 65 |
|
|
2025
Q1 | $1.06M | Sell |
9,463
-754
| -7% | -$77.8K | 0.37% | 70 |
|
|
2024
Q4 | $944K | Sell |
10,217
-377
| -4% | -$33.9K | 0.33% | 75 |
|
|
2024
Q3 | $888K | Sell |
10,594
-437
| -4% | -$33.3K | 0.31% | 82 |
|
|
2024
Q2 | $757K | Sell |
11,031
-508
| -4% | -$33.9K | 0.29% | 86 |
|
|
2024
Q1 | $84.2K | Sell |
11,539
-3,169
| -22% | -$244K | 0.03% | 168 |
|
|
2023
Q4 | $1.19M | Buy |
14,708
+1,642
| +13% | +$128K | 0.49% | 57 |
|
|
2023
Q3 | $979K | Buy |
13,066
+193
| +1% | +$14.8K | 0.43% | 66 |
|
|
2023
Q2 | $992K | Buy |
12,873
+104
| +0.8% | +$8.29K | 0.41% | 69 |
|
|
2023
Q1 | $1.06M | Sell |
12,769
-46
| -0.4% | -$3.81K | 0.45% | 67 |
|
|
2022
Q4 | $1.1M | Sell |
12,815
-367
| -3% | -$29.1K | 0.49% | 64 |
|
|
2022
Q3 | $813K | Buy |
13,182
+6,266
| +91% | +$395K | 0.36% | 79 |
|
|
2022
Q2 | $428K | Buy |
6,916
+362
| +6% | +$22.4K | 0.19% | 120 |
|
|
2022
Q1 | $390K | Buy |
6,554
+351
| +6% | +$22.4K | 0.15% | 127 |
|
|
2021
Q4 | $450K | Buy |
6,203
+201
| +3% | +$13.8K | 0.18% | 115 |
|
|
2021
Q3 | $419K | Buy |
6,002
+1
| +0% | +$70 | 0.18% | 114 |
|
|
2021
Q2 | $413K | Buy |
6,001
+176
| +3% | +$11.8K | 0.18% | 117 |
|
|
2021
Q1 | $376K | Buy |
5,825
+1,771
| +44% | +$114K | 0.18% | 115 |
|
|
2020
Q4 | $236K | Buy |
4,054
+1
| +0% | +$60 | 0.11% | 134 |
|
|
2020
Q3 | $256K | Buy |
4,053
+1
| +0% | +$69 | 0.15% | 124 |
|
|
2020
Q2 | $312K | Sell |
4,052
-3,365
| -45% | -$258K | 0.19% | 105 |
|
|
2020
Q1 | $555K | Sell |
7,417
-1,851
| -20% | -$128K | 0.41% | 67 |
|
|
2019
Q4 | $602K | Hold |
9,268
| – | – | 0.36% | 79 |
|
|
2019
Q3 | $587K | Sell |
9,268
-719
| -7% | -$47K | 0.38% | 78 |
|
|
2019
Q2 | $675 | Sell |
9,987
-94
| -0.9% | -$6.18K | 0.17% | 72 |
|
|
2019
Q1 | $655K | Sell |
10,081
-49
| -0.5% | -$3.26K | 0.45% | 61 |
|
|
2018
Q4 | $633K | Buy |
10,130
+76
| +0.8% | +$5.31K | 0.41% | 67 |
|
|
2018
Q3 | $776K | Buy |
10,054
+1
| +0% | +$76 | 0.53% | 53 |
|
|
2018
Q2 | $712K | Sell |
10,053
-124
| -1% | -$8.76K | 0.49% | 59 |
|
|
2018
Q1 | $767K | Sell |
10,177
-50
| -0.5% | -$3.98K | 0.54% | 59 |
|
|
2017
Q4 | $732K | Buy |
+10,227
| New | +$777K | 0.47% | 66 |
|
Other funds holding GILD
Cornell Pochily Investment Advisors's GILD Position: Q2 2026 in Review
Cornell Pochily Investment Advisors reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $16.7K and leaving 10,724 shares worth $1.35M. The position accounts for 0.36% of the portfolio, ranked #70.
Cornell Pochily Investment Advisors first reported a position in GILD in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.51M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cornell Pochily Investment Advisors held 10,724 shares of Gilead Sciences worth $1.35M as of Q2 2026.
- Cornell Pochily Investment Advisors sold 127 Gilead Sciences shares in Q2 2026, an estimated $16.7K.
- Gilead Sciences made up 0.36% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #70 holding.
- Cornell Pochily Investment Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 35 quarters since.
- Cornell Pochily Investment Advisors's Gilead Sciences position peaked at $1.51M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.